{
  "docId": "019de517-ef27-7380-abf1-7804147a21c1",
  "docSlug": "35bb8af5e32b82874d7685e3939f2cc9",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 39 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 39,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 40,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de517-ef27-7380-abf1-7804147a21c1/14",
  "deckHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1",
  "deckJsonHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1.json",
  "deckAnchorHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.02,
        "w": 0.099,
        "x": 0.043,
        "y": 0.94
      },
      "kind": "image",
      "text": "BAUSCH+LOMB",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "089ee4a1-4ae3-45aa-bbba-93a4e80a20c1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.774,
        "x": 0.154,
        "y": 0.918
      },
      "kind": "source-note",
      "text": "1. Products with sales outside the United States impacted by F/X changes.\n2. This is a non-GAAP measure or ratio. See Slide 1 and Appendix for further information on non-GAAP measures and ratios.\n3. Effective in the first quarter of 2023, certain products historically included in the reported results of the Pharmaceuticals segment are now included in the reported results of the Vision Care segment and certain products included in the reported results\nof the Vision Care segment are now included in the reported results of the Pharmaceuticals segment. Management believes these movements are necessary in order to better align these products with the groupings of similar products. The net\nimpact of these product movements was not material to the periods presented. Prior period presentations of segment revenues have been conformed to the current segment reporting structure.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f5f917e2-d298-4b2c-b2b7-da141afb631f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.72,
        "w": 0.899,
        "x": 0.048,
        "y": 0.157
      },
      "kind": "table",
      "text": "Bausch + Lomb FY23 FY22 Reported Change Constant Currency Change2 Vision Care Revenue3 $2,543M $2,369M 7% 10% Surgical Revenue $767M $718M 7% 7% Pharmaceuticals Revenue3 $836M $681M 23% 24% Total Revenue $4,146M $3,768M 10% 12% Gross Profit $2,264M $2,004M 13% 15% Gross Margin 54.6% 53.2% 140 bps R&D $324M $307M (6%) (6%) R&D % of Revenue 7.8% 8.1% SG&A $1,736M $1,478M (17%) (19%) SG&A % of Revenue 41.9% 39.2% Operating Income $130M $207M Net (Loss) Income Attributable to B+L ($260M) $6M Net (Loss) Income Margin (6.3%) 0.2% EPS Attributable to B+L ($0.74) $0.02",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50294dd3-5a7f-4cf5-b500-804a77046c40",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.607,
        "x": 0.048,
        "y": 0.049
      },
      "kind": "title",
      "text": "FY23 Bausch + Lomb P&L¹ (GAAP)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1acd3095-3a45-4aac-aa07-1cdb1067b583",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 8,
      "beatId": "d6fbc6e1-824b-4798-aac9-27095aa32da2",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Desire",
      "beatSlug": "aida-desire",
      "evidence": "The financial results and segment performance create a desire to learn more",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 9,
      "name": "Zoom In",
      "slug": "06-zoom-in",
      "bestFor": "Technical deep-dives, case studies, detailed analysis",
      "matchId": "11fd2762-3225-4b01-8777-53698056e053",
      "evidence": "The document zooms in on revenue drivers and financial performance",
      "position": 0,
      "objective": "What drives revenue growth?",
      "structure": "The Big Picture -> Key Area of Focus -> Specific Detail -> Implication",
      "confidence": 0.7,
      "description": "Start broad, then progressively focus on specific details that prove your point"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}